SBC Medical ( $SBC ) has started building its own biological age test using DNA methylation analysis, led by its SBC AI Longevity Innovation subsidiary with research from the Waqoo Group. In Q2 2026, revenue rose 13% to $49 million and adjusted EBITDA rose 32% to $20 million.
prismmarketview.com/sbc-medi…
⚖️ Critical Metals $CRML just won Australian court approval for its European Lithium takeover.✅ Holders get 0.045 CRML shares each, the top of the range
📅 Deal closes Nov. 5
🚀 New shares are set to start trading on Nasdaq Nov. 6Full story on PRISM MarketView 👇
prismmarketview.com/critical…

ALT Critical Metals Corp. (NASDAQ: CRML) cleared the last major hurdle in its takeover of European Lithium on Monday. The Supreme Court of Western Australia approved both schemes of arrangement, one covering European Lithium’s shares and one covering its listed options. The ruling comes four days after European Lithium securityholders voted overwhelmingly in favor. The deal now moves to implementation, and new CRML shares are expected to begin trading on Nasdaq on November 6.
BioLineRx ($BLRX) and Hemispherian presented data at ESMO: GLIX1 boosted PARP inhibitor activity in HR-proficient ovarian cancer models. Preclinical only.
prismmarketview.com/bioliner…
PRISM Digital Media retweeted
Lucid Diagnostics ($LUCD) began receiving Medicare payments for its EsoGuard esophageal DNA test at the established fee schedule rate of $1,938.01 per test. It also closed a $15M Series C preferred placement with existing shareholders.
Payments are coming in for tests run at its Texas lab. Noteholders in the deal said the payments addressed the concerns behind a Medicare-related default provision in its 2029 convertible notes.
California lab claims still await a final revised coverage determination, and the Series C converts at $0.3519 with a 20% dividend paid in stock.
prismmarketview.com/lucid-di…
PRISM Digital Media retweeted
October is National Physical Therapy Month, and this year’s “PT For Future Me” theme is about strength and mobility for life, not just recovery.
Five public companies are working on different stages of it:
$KIDS: pediatric orthopedics, where lifelong mobility starts
$OMDA: a physical therapist-designed exercise plan that helped GLP-1 users lose more weight while gaining muscle
$ENOV: braces, recovery tools and joint replacements, from injury to rehab
$MYO: the MyoPro powered arm brace, restoring function after stroke and injury
$FIGS: outfitting the professionals who make it all work prismmarketview.com/national… #PTForFutureMe
PRISM Digital Media retweeted
Bloom Energy ($BE) reported record Q3 revenue of $1.24B, up 138% year over year, as product revenue rose 179% to $1.07B. Operating income reached $225.4M, up $217.6M, and gross margin widened to 33.8%.
The company raised its full-year 2026 revenue guidance to $4.4B to $4.6B, about 122% growth at the midpoint, and was added to the S&P 500.
prismmarketview.com/companie…
$CRLBF: Sunnyside Prestonsburg (KY) opens, Cresco’s 83rd dispensary
→ Kentucky medical program now has dispensaries in all 11 regions (company statement)
→ Eastern Kentucky location; medical patients only
#CRLBF #Cannabis #MedicalCannabis #Kentucky
prismmarketview.com/companie…
BriaCell ($BCTX) presented an ESMO 2026 poster: in 111 metastatic breast cancer patients, post-treatment CAML PD-L1 was linked to survival. Pooled; not proof of Bria-IMT benefit.
prismmarketview.com/briacell…
🔐 BIO-key $BKYI jumped 30.5% to $2.74 and is up again premarket after winning its 7th Gulf government customer in 6 months.
A national security institution is deploying PortalGuard, Passkey:YOU and EcoID III.
It's leading the PRISM Cybersecurity Index 👇
prismmarketview.com/bio-key-…
($SKYX)
@skyxplatforms and Deako plan to supply 80,000+ smart-home units for 1,000+ Maronda Homes residences in 2027. No financial terms or revenue disclosed.
prismmarketview.com/skyx-and…
PRISM Digital Media retweeted
PRISM M☀️RNING M☀️VERS
Premarket Gainers:
J-Star Holding Co., Ltd. ($YMAT) - up 62%
WISeSat.Space Holdings Corp. ($SAIQ) - up 26%
RingCentral, Inc. ($RNG) - up 15%
BIO-key International, Inc. ($BKYI) - up 12%
Premarket Decliners:
Davion Healthcare Plc Ordinary Shares ($DAVI) - down 40%
Tantech Holdings Ltd ($TANH) - down 38%
Stock prices and percentage changes are as of 8:30 a.m. ET on October 23, 2026, and are subject to change.
$BKYI
BIO-key International won another Middle East government contract for its PortalGuard passwordless biometric identity platform. It is BIO-key's seventh new customer in the Gulf region in the past six months. prismmarketview.com/companie…
$FUBO
fuboTV Inc. signed seven new regional sports network deals for the 2026-27 NBA season, covering teams including the Hawks, Pistons, HEAT, Bucks and Thunder. Its NBA RSN market coverage now tops 75%.
prismmarketview.com/companie…
$DMAC
DiaMedica Therapeutics enrolled the 200th patient in its Phase 2/3 ReMEDy2 acute ischemic stroke trial of DM199, reaching the threshold for a planned interim analysis. Results are expected in Q1 2027.
prismmarketview.com/companie…
PRISM Digital Media retweeted
National Pharmacy Week runs October 18 to 24. Organized by ASHP, it recognizes the contributions pharmacists and technicians make to patient care in hospitals, outpatient clinics and other healthcare settings.
Pharmacists help make sure medication use is safe and patients reach the best possible outcomes. Thank you to the pharmacy teams doing that work every day.
Crypto miners got hit hard today ⛏️📉
The PRISM Crypto Mining Index fell 6%, with all 16 members down. Bitcoin slipped below $82K as Tesla and Meta earnings revived doubts about AI spending, and oil stayed high.
$IREN $CIFR $BTDR $GLXY each fell ~8%.
$NEWP $IAG $CDE $HL $MUX
Full story 👇
prismmarketview.com/crypto-m…
Verrica ($VRCA) gained access to the full $27.5M credit facility ($12.5M already funded). Debt carries a 12.5% minimum rate; lender is its chairman’s entity.
prismmarketview.com/verrica-…
Korro Bio ($KRRO) reported preclinical data for KRRO-111 in AATD: up to 96% RNA editing in mice. Regulatory submission targeted 1H 2027. No human data yet.
prismmarketview.com/korro-re…
Sagimet ($SGMT) dosed the first patient in AURORA, its pivotal U.S. Phase 3 acne trial of denifanstat. Topline results expected 2H 2027. Not approved; no guarantee of success.
prismmarketview.com/sagimet-…
$LNZA LanzaTech Global said a Hebei Shoulang facility using its technology earned the world's first ISCC EU Recycled Carbon Fuel certification for ethanol made from steel mill waste gases.
prismmarketview.com/companie…









